Editor's Note
Food & Drug Administration (FDA) approval of Pfizer’s COVID-19 vaccine could happen in October, the July 12 Time reports. The company was granted FDA Fast Track designation for the vaccine.
Pfizer’s vaccine, being developed with its German biotech partner BioNTech, uses a messenger-RNA, genetics-based approach.
Pfizer CEO Albert Bourla says they should have enough data by September on the success of the vaccine to submit to the FDA. The company plans to begin manufacturing the vaccine ahead of FDA approval.
Read More >>The kind of Navy-taught leadership Brian Dawson, MSN, RN-BC, CNOR,…
Remote surgery has come a long way since the first-ever…
Every day, I come across postings in the media suggesting…